# A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS

Source: https://onco.cc/trials/nct06906471/  
OnCo record `nct06906471` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of AS1986NS in prostate cancer, run by Antelope Surgical Solutions, Inc, now recruiting.

## Summary

A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS is a phase 1/2 interventional study registered as NCT06906471 by Antelope Surgical Solutions, Inc, with 10 participants planned, started 2026-07-01 and due to reach its primary completion in 2026-10-30. Interventions recorded: AS1986NS.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06906471
- Phase: 1/2
- Setting: A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS
- Sponsor: Antelope Surgical Solutions, Inc
- Enrolled: 10

## Sources

- ClinicalTrials.gov NCT06906471: https://clinicaltrials.gov/study/NCT06906471

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)

---
JSON: https://onco.cc/api/v1/entities/nct06906471.json